Annovis Bio (ANVS) Stock Chart & Stock Price History $2.77 +0.11 (+4.14%) Closing price 03:59 PM EasternExtended Trading$2.73 -0.04 (-1.44%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Annovis Bio Stock Price Performance The Annovis Bio (ANVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.84%, with a year-to-date return of -44.93%. In the past month, the stock has increased 27.06%, reflecting recent market activity. As of the latest close, Annovis Bio traded at $2.66 with a market cap of $51.76 million and volume of 451,034 shares. Receive ANVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.97%1 Month Performance+27.06%3 Month Performance+84.67%Year-To-Date Performance-44.93%1 Year Performance-70.84% ANVS Stock Chart for Wednesday, July, 30, 2025 ANVS Chart by TradingView Annovis Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$2.94$2.66-9.66%$2.95$2.63451,034 shs$51.76 million07/28/2025$2.92$2.94+0.86%$2.97$2.79269,693 shs$57.30 million07/25/2025$2.86$2.92+1.96%$3.00$2.77452,468 shs$56.81 million07/24/2025$2.64$2.86+8.50%$2.89$2.62519,853 shs$55.72 million07/23/2025$2.61$2.64+1.07%$2.70$2.53366,485 shs$51.35 million07/22/2025$2.53$2.61+3.04%$2.63$2.52188,252 shs$50.81 million07/21/2025$2.66$2.53-4.82%$2.75$2.52227,018 shs$49.31 million07/18/2025$2.82$2.66-5.74%$2.83$2.63475,137 shs$51.80 million07/17/2025$2.79$2.82+1.18%$2.89$2.72306,909 shs$54.95 million07/16/2025$2.70$2.79+3.41%$2.85$2.63280,914 shs$54.32 million Get the Latest News and Ratings for ANVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$2.87$2.70-5.93%$2.92$2.64222,830 shs$52.53 million07/14/2025$2.72$2.87+5.33%$2.91$2.63303,517 shs$55.84 million07/11/2025$2.88$2.72-5.56%$2.85$2.70330,191 shs$53.01 million07/10/2025$2.71$2.88+6.27%$2.97$2.72366,024 shs$56.12 million07/09/2025$2.53$2.71+7.11%$2.78$2.57337,446 shs$52.82 million07/08/2025$2.39$2.53+5.86%$2.79$2.35644,740 shs$49.31 million07/07/2025$2.39$2.39+0.21%$2.43$2.24333,083 shs$46.57 million07/04/2025$2.39$2.39$2.48$2.34191,018 shs$46.48 million07/03/2025$2.38$2.39+0.21%$2.48$2.34191,018 shs$46.47 million07/02/2025$2.34$2.38+1.71%$2.46$2.31285,827 shs$46.39 million07/01/2025$2.18$2.34+7.34%$2.37$2.10358,322 shs$45.61 million06/30/2025$2.10$2.18+4.01%$2.22$2.06284,407 shs$42.49 million Related Companies ALX Oncology Stock Chart Larimar Therapeutics Stock Chart Canopy Growth Stock Chart 4D Molecular Therapeutics Stock Chart Y-mAbs Therapeutics Stock Chart Organigram Global Stock Chart enGene Stock Chart Rapt Therapeutics Stock Chart CytomX Therapeutics Stock Chart China SXT Pharmaceuticals Stock Chart Receive ANVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANVS) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annovis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annovis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.